Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP972100priorityCriticalpatent/ECSP972100A/en
Publication of ECSP972100ApublicationCriticalpatent/ECSP972100A/en
Un uso provisto de una combinación de IL-10 y un esteroide para la manufactura de un medicamento para el tratamiento o prevención de una enfermedad inflamatoria, en particular shock séptico y condiciones inflamatorias causadas por enfermedades autoinmunes, enfermedad inflamatoria de intestinos, artritis reumatoide, esclerosis múltiple, uveitis y psoriasis. También se provee composiciones farmacéuticas y equipos que comprenden IL-10 más por lo menos un esteroide, por ejemplo betametazona o sus derivados.A use provided with a combination of IL-10 and a steroid for the manufacture of a medicament for the treatment or prevention of an inflammatory disease, in particular septic shock and inflammatory conditions caused by autoimmune diseases, inflammatory bowel disease, rheumatoid arthritis, sclerosis multiple, uveitis and psoriasis. Pharmaceutical compositions and kits comprising IL-10 plus at least one steroid, for example betamethasone or its derivatives, are also provided.
ECSP9721001997-04-301997-04-30
METHOD FOR TREATING INFLAMMATION
ECSP972100A
(en)
2-AMINO-6-METHYL-7-ACETYL-TETRALIN AND PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND THERAPEUTIC TREATMENT OF INFLAMMATORY AND/OR AUTOIMMUNE DISEASES
ANTI-CONCEPTIVE KIT THAT INCLUDES MEANS FOR THE DAILY ADMINISTRATION OF A UNIQUE ANTI-CONCEPTIVE AGENT THAT IS A STEROID COMPOSITE THAT COMBINES THE PROGESTAGENIC AND STROGENIC ACTIVITIES